Compass Oncology - Rose Quarter — Portland, Oregon

Compass Oncology - Rose Quarter is a clinical research site located in Portland, Oregon, United States 97227.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Compass Oncology - Rose Quarter has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma.

Sponsors: Genmab.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Compass Oncology - Rose Quarter?

Compass Oncology - Rose Quarter has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Compass Oncology - Rose Quarter conducted?

Compass Oncology - Rose Quarter has 1 clinical trials on record, with 1 currently active. Their work covers High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma.

Is Compass Oncology - Rose Quarter accredited by Crixeo Health?

Compass Oncology - Rose Quarter has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Compass Oncology - Rose Quarter?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.